Two Sigma Securities, LLC Invitae Corp Transaction History

Two Sigma Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.42 - $0.72 $2,107 - $3,613	5,019 Added 40.84%	17,309 $10,000
Q3 2023 Nov 14, 2023	SELL	$0.6 - $1.53 $26,328 - $67,136	-43,880 Reduced 78.12%	12,290 $7,000
Q2 2023 Aug 14, 2023	BUY	$1.05 - $1.63 $14,708 - $22,833	14,008 Added 33.22%	56,170 $63,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $50,594 - $115,102	42,162 New	42,162 $56,000
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $44,619 - $202,666	-23,484 Reduced 44.18%	29,672 $73,000

Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $86,394 - $365,454	40,561 Added 322.04%	53,156 $130,000
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $79,096 - $196,356	12,595 New	12,595 $100,000
Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $134,931 - $263,161	-9,179 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $223,141 - $308,414	9,179 New	9,179 $261,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.